Iron and Cancer.

This review explores the multifaceted role that iron has in cancer biology. Epidemiological studies have demonstrated an association between excess iron and increased cancer incidence and risk, while experimental studies have implicated iron in cancer initiation, tumor growth, and metastasis. The roles of iron in proliferation, metabolism, and metastasis underpin the association of iron with tumor growth and progression. Cancer cells exhibit an iron-seeking phenotype achieved through dysregulation of iron metabolic proteins. These changes are mediated, at least in part, by oncogenes and tumor suppressors. The dependence of cancer cells on iron has implications in a number of cell death pathways, including ferroptosis, an iron-dependent form of cell death. Uniquely, both iron excess and iron depletion can be utilized in anticancer therapies. Investigating the efficacy of these therapeutic approaches is an area of active research that promises substantial clinical impact.

[1]  S. Petrillo,et al.  The Multifaceted Role of Heme in Cancer , 2020, Frontiers in Oncology.

[2]  Yanhong Zhang,et al.  Mdm2 is a target and mediator of IRP2 in cell growth control , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  S. Gandini,et al.  Carcinogenicity of High Consumption of Meat and Lung Cancer Risk Among Non-Smokers: A Comprehensive Meta-Analysis , 2018, Nutrition and cancer.

[4]  B. Stockwell,et al.  Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.

[5]  T. Bai,et al.  Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells. , 2017, Biochemical and biophysical research communications.

[6]  V. Khanna,et al.  Estimation of serum ferritin level in potentially malignant disorders, oral squamous cell carcinoma, and treated cases of oral squamous cell carcinoma , 2017, Journal of cancer research and therapeutics.

[7]  A. Beggs,et al.  BRAF mutations are associated with increased iron regulatory protein‐2 expression in colorectal tumorigenesis , 2017, Cancer science.

[8]  A. Schneeweiss,et al.  Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2) , 2017, Breast Cancer Research and Treatment.

[9]  Brian J. Smith,et al.  O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate. , 2017, Cancer cell.

[10]  G. Ning,et al.  Iron addiction: A novel therapeutic target in ovarian cancer , 2017, Oncogene.

[11]  L. Schöckel,et al.  Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells , 2017, Cell Death and Disease.

[12]  N. D. Turner,et al.  Association between red meat consumption and colon cancer: A systematic review of experimental results , 2017, Experimental biology and medicine.

[13]  E. Yamazaki,et al.  Serum ferritin level is a prognostic marker in patients with peripheral T‐cell lymphoma , 2017, International journal of laboratory hematology.

[14]  Nicholas F. Marko,et al.  Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas , 2016, PloS one.

[15]  J. Ho,et al.  Dietary Protein Sources and Incidence of Breast Cancer: A Dose-Response Meta-Analysis of Prospective Studies , 2016, Nutrients.

[16]  B. Shi,et al.  EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1. , 2016, Cancer letters.

[17]  B. Győrffy,et al.  Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis. , 2016, Cell metabolism.

[18]  Q. Pan,et al.  Ferroptosis is an autophagic cell death process , 2016, Cell Research.

[19]  G. Ichim,et al.  A fate worse than death: apoptosis as an oncogenic process , 2016, Nature Reviews Cancer.

[20]  Anna Song,et al.  Serum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer , 2016, Journal of Cancer.

[21]  R. Stolzenberg-Solomon,et al.  Are meat and heme iron intake associated with pancreatic cancer? Results from the NIH‐AARP diet and health cohort , 2016, International journal of cancer.

[22]  O. Franco,et al.  Dietary mineral intake and lung cancer risk: the Rotterdam Study , 2016, European Journal of Nutrition.

[23]  M. Rauh,et al.  Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema , 2016, Oncotarget.

[24]  Gretchen L. Gierach,et al.  Red and processed meat, nitrite, and heme iron intakes and postmenopausal breast cancer risk in the NIH‐AARP Diet and Health Study , 2016, International journal of cancer.

[25]  T. Ganz,et al.  Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics. , 2016, Biochimica et biophysica acta.

[26]  F. Torti,et al.  Iron and cancer: recent insights , 2016, Annals of the New York Academy of Sciences.

[27]  D. Alexander,et al.  A review and meta-analysis of prospective studies of red and processed meat, meat cooking methods, heme iron, heterocyclic amines and prostate cancer , 2015, Nutrition Journal.

[28]  A. Tjønneland,et al.  Body iron status and gastric cancer risk in the EURGAST study , 2015, International journal of cancer.

[29]  W. Berger,et al.  Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy , 2015, Oncotarget.

[30]  Nupur K. Das,et al.  Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells. , 2015, Cancer cell.

[31]  A. Pietrangelo Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin. , 2015, Gastroenterology.

[32]  W. Willett,et al.  Processed and Unprocessed Red Meat and Risk of Colorectal Cancer: Analysis by Tumor Location and Modification by Time , 2015, PloS one.

[33]  Minghui Gao,et al.  Glutaminolysis and Transferrin Regulate Ferroptosis. , 2015, Molecular cell.

[34]  B. Stockwell,et al.  Elucidating Compound Mechanism of Action by Network Perturbation Analysis , 2015, Cell.

[35]  L. Miller,et al.  Hepcidin regulation in prostate and its disruption in prostate cancer. , 2015, Cancer research.

[36]  Nils Eling,et al.  Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells , 2015, Oncoscience.

[37]  P. Adams,et al.  Epidemiology and diagnostic testing for hemochromatosis and iron overload , 2015, International journal of laboratory hematology.

[38]  Wei Wei,et al.  Red and processed meat intake and risk of breast cancer: a meta-analysis of prospective studies , 2015, Breast Cancer Research and Treatment.

[39]  N. Naud,et al.  A central role for heme iron in colon carcinogenesis associated with red meat intake. , 2015, Cancer research.

[40]  Panagiotis K. Papasaikas,et al.  Genome-wide identification of Fas/CD95 alternative splicing regulators reveals links with iron homeostasis. , 2015, Molecular cell.

[41]  Panagiotis K. Papasaikas,et al.  Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery. , 2014, Molecular cell.

[42]  Daoqiang Zhang,et al.  Disordered hepcidin-ferroportin signaling promotes breast cancer growth. , 2014, Cellular signalling.

[43]  John A. Tallarico,et al.  Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo , 2014, Nature Cell Biology.

[44]  Nishant Bhatta,et al.  The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway , 2014, Oncotarget.

[45]  T. Ganz,et al.  Anemia of inflammation. , 2014, Hematology/oncology clinics of North America.

[46]  K. Matsuo,et al.  Meat consumption and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. , 2014, Japanese journal of clinical oncology.

[47]  X. Xue,et al.  Red and processed meat consumption and the risk of lung cancer: a dose-response meta-analysis of 33 published studies. , 2014, International journal of clinical and experimental medicine.

[48]  M. Fleming,et al.  SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1 , 2014, Oncogene.

[49]  G. Waeber,et al.  Physiology of Iron Metabolism , 2014, Transfusion Medicine and Hemotherapy.

[50]  M. McDevitt,et al.  A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms , 2014, Haematologica.

[51]  M. Minden,et al.  Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies , 2014, American journal of hematology.

[52]  Douglas B Kell,et al.  Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. , 2014, Metallomics : integrated biometal science.

[53]  Tom C. Karagiannis,et al.  Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy , 2014, The Journal of Membrane Biology.

[54]  Yan Ma,et al.  High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy , 2014, Science Translational Medicine.

[55]  R. Kelishadi,et al.  Review on iron and its importance for human health , 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[56]  L. Miller,et al.  IRP2 regulates breast tumor growth. , 2014, Cancer research.

[57]  Hong-yan Cheng,et al.  Meat Consumption Is Associated with Esophageal Cancer Risk in a Meat- and Cancer-Histological-Type Dependent Manner , 2014, Digestive Diseases and Sciences.

[58]  J. Gohagan,et al.  The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. , 2013, Journal of the National Cancer Institute.

[59]  A. Agudo,et al.  Iron and Cancer Risk—A Systematic Review and Meta-analysis of the Epidemiological Evidence , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[60]  Shun-Fa Yang,et al.  Knockdown of lipocalin‐2 suppresses the growth and invasion of prostate cancer cells , 2013, The Prostate.

[61]  Antonina Rait,et al.  Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[62]  F. Torti,et al.  Iron and cancer: more ore to be mined , 2013, Nature Reviews Cancer.

[63]  E. Verdin,et al.  Sirtuin-3 (SIRT3) and the Hallmarks of Cancer. , 2013, Genes & cancer.

[64]  D. Berg,et al.  Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial , 2013, Cancer Chemotherapy and Pharmacology.

[65]  D. Greenwood,et al.  Red and processed meat intake and risk of colorectal adenomas: a systematic review and meta-analysis of epidemiological studies , 2013, Cancer Causes & Control.

[66]  M. Zheng,et al.  Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway , 2013, Molecular Pharmacology.

[67]  D. Richardson,et al.  The Iron Chelator, Deferasirox, as a Novel Strategy for Cancer Treatment: Oral Activity Against Human Lung Tumor Xenografts and Molecular Mechanism of Action , 2013, Molecular Pharmacology.

[68]  E. Vogtmann,et al.  Meat consumption and risk of lung cancer: evidence from observational studies. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[69]  R. Goldbohm,et al.  Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort Study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[70]  E. McGhee,et al.  Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo. , 2012, Cell reports.

[71]  Y. Kanai,et al.  Fenton Reaction Induced Cancer in Wild Type Rats Recapitulates Genomic Alterations Observed in Human Cancer , 2012, PloS one.

[72]  F. Clavel-Chapelon,et al.  Dietary intake of heme iron and risk of gastric cancer in the European prospective investigation into cancer and nutrition study , 2012, International journal of cancer.

[73]  D. Steensma,et al.  Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  C. Santos,et al.  STEAP Proteins: From Structure to Applications in Cancer Therapy , 2012, Molecular Cancer Research.

[75]  M. Cappellini,et al.  Iron overload in non-transfusion-dependent thalassemia: a clinical perspective. , 2012, Blood reviews.

[76]  J. Imlay,et al.  Mononuclear Iron Enzymes Are Primary Targets of Hydrogen Peroxide Stress* , 2012, The Journal of Biological Chemistry.

[77]  W. Turski,et al.  Main dietary compounds and pancreatic cancer risk. The quantitative analysis of case-control and cohort studies. , 2012, Cancer epidemiology.

[78]  S. Larsson,et al.  Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies , 2012, British Journal of Cancer.

[79]  Suzy V. Torti,et al.  An iron regulatory gene signature predicts outcome in breast cancer. , 2011, Cancer research.

[80]  Dana Pe'er,et al.  Modulatory profiling identifies mechanisms of small molecule-induced cell death , 2011, Proceedings of the National Academy of Sciences.

[81]  S. Terai,et al.  Deferoxamine for advanced hepatocellular carcinoma. , 2011, The New England journal of medicine.

[82]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[83]  Yun Wu,et al.  Relationships of lipocalin 2 with breast tumorigenesis and metastasis , 2011, Journal of cellular physiology.

[84]  F. Pierre,et al.  Heme Iron from Meat and Risk of Colorectal Cancer: A Meta-analysis and a Review of the Mechanisms Involved , 2011, Cancer Prevention Research.

[85]  P. Mink,et al.  A review and meta-analysis of red and processed meat consumption and breast cancer , 2010, Nutrition Research Reviews.

[86]  Dominik D Alexander,et al.  A review and meta-analysis of prospective studies of red and processed meat intake and prostate cancer , 2010, Nutrition journal.

[87]  A. Ganser,et al.  Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study. , 2010, Leukemia research.

[88]  G. Pinkus,et al.  CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens. , 2010, American journal of clinical pathology.

[89]  M. Willingham,et al.  Ferroportin and iron regulation in breast cancer progression and prognosis. , 2010, Science translational medicine.

[90]  R. Strong,et al.  Iron Traffics in Circulation Bound to a Siderocalin (Ngal)-Catechol Complex , 2010, Nature chemical biology.

[91]  C. Ouzounis,et al.  Tumorigenic Properties of Iron Regulatory Protein 2 (IRP2) Mediated by Its Specific 73-Amino Acids Insert , 2010, PloS one.

[92]  D. Alexander,et al.  Meta‐Analysis of Prospective Studies of Red Meat Consumption and Colorectal Cancer , 2010, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[93]  L. Valenti,et al.  Hemochromatosis gene (HFE) mutations and cancer risk: Expanding the clinical manifestations of hereditary iron overload , 2010, Hepatology.

[94]  J. Kolesar,et al.  A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503 , 2010, Investigational New Drugs.

[95]  M. Bredel,et al.  Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults , 2009, BMC Cancer.

[96]  C. McCarty,et al.  Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2009, British Journal of Cancer.

[97]  R. Sinha,et al.  A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. , 2009, The American journal of clinical nutrition.

[98]  P. Kochanek,et al.  Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. , 2009, Free radical biology & medicine.

[99]  M. Diederich,et al.  Linking anemia to inflammation and cancer: the crucial role of TNFalpha. , 2009, Biochemical pharmacology.

[100]  F. Torti,et al.  Post-transcriptional Modulation of Iron Homeostasis during p53-dependent Growth Arrest* , 2008, Journal of Biological Chemistry.

[101]  P. Kyyrönen,et al.  Exposure to iron and welding fumes and the risk of lung cancer. , 2008, Scandinavian journal of work, environment & health.

[102]  P. Lavori,et al.  Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. , 2008, Journal of the National Cancer Institute.

[103]  P. Oates,et al.  Mechanisms of heme iron absorption: current questions and controversies. , 2008, World journal of gastroenterology.

[104]  B. Stockwell,et al.  Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. , 2008, Chemistry & biology.

[105]  Rebecca C Taylor,et al.  Apoptosis: controlled demolition at the cellular level , 2008, Nature Reviews Molecular Cell Biology.

[106]  B. Cooper,et al.  A role for iron in Wnt signalling , 2008, Oncogene.

[107]  L. Wideroff,et al.  Cancer incidence in blood transfusion recipients. , 2007, Journal of the National Cancer Institute.

[108]  Robin Mathew,et al.  Role of autophagy in cancer , 2007, Nature Reviews Cancer.

[109]  I. Orienti,et al.  Sodium Ascorbate induces apoptosis in neuroblastoma cell lines by interfering with iron uptake , 2007, Molecular Cancer.

[110]  E. Eisenhauer,et al.  Phase II study of Triapine® in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161) , 2007, Investigational New Drugs.

[111]  G. Berx,et al.  Modulation of iron transport proteins in human colorectal carcinogenesis , 2006, Gut.

[112]  Y. Aida,et al.  Human immunodeficiency virus type 1 Vpr induces cell cycle arrest at the G(1) phase and apoptosis via disruption of mitochondrial function in rodent cells. , 2006, Microbes and infection.

[113]  D. Ovcharenko,et al.  Neutrophil gelatinase-associated lipocalin as a survival factor. , 2005, The Biochemical journal.

[114]  Jiahuai Han,et al.  Distinct Roles of Basal Steady-State and Induced H-Ferritin in Tumor Necrosis Factor-Induced Death in L929 Cells , 2005, Molecular and Cellular Biology.

[115]  Shizuo Akira,et al.  Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron , 2004, Nature.

[116]  Mark H Ellisman,et al.  Disruption of Mitochondrial Function during Apoptosis Is Mediated by Caspase Cleavage of the p75 Subunit of Complex I of the Electron Transport Chain , 2004, Cell.

[117]  M. Brechbiel,et al.  Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator. , 2004, Biochemical Pharmacology.

[118]  J. Verrax,et al.  Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death , 2004, Apoptosis.

[119]  J. Lambeth NOX enzymes and the biology of reactive oxygen , 2004, Nature Reviews Immunology.

[120]  J. Freudenheim,et al.  Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. , 2004, Annals of epidemiology.

[121]  Wim Declercq,et al.  Differential Signaling to Apoptotic and Necrotic Cell Death by Fas-associated Death Domain Protein FADD* , 2004, Journal of Biological Chemistry.

[122]  Xi Huang Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. , 2003, Mutation research.

[123]  J. Dipersio,et al.  Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia. , 2003, Leukemia research.

[124]  R. Hultcrantz,et al.  Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. , 2003, Gastroenterology.

[125]  R. Kittles,et al.  Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. , 2003, Blood cells, molecules & diseases.

[126]  R. Weissleder,et al.  The transferrin receptor: a potential molecular imaging marker for human cancer. , 2003, Neoplasia.

[127]  D. Richardson,et al.  The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1. , 2003, Carcinogenesis.

[128]  Michael Hambidge,et al.  Biomarkers of trace mineral intake and status. , 2003, The Journal of nutrition.

[129]  E. Pietsch,et al.  Nrf2 Mediates the Induction of Ferritin H in Response to Xenobiotics and Cancer Chemopreventive Dithiolethiones* , 2003, The Journal of Biological Chemistry.

[130]  S. Bingham,et al.  Effect of white versus red meat on endogenous N-nitrosation in the human colon and further evidence of a dose response. , 2002, The Journal of nutrition.

[131]  M. Willingham,et al.  Activation of Caspase Pathways during Iron Chelator-mediated Apoptosis* , 2002, The Journal of Biological Chemistry.

[132]  M. Willingham,et al.  p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator. , 2001, Carcinogenesis.

[133]  P. Aisen,et al.  Chemistry and biology of eukaryotic iron metabolism. , 2001, The international journal of biochemistry & cell biology.

[134]  C. Beaumont,et al.  Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[135]  Bruno Turlin,et al.  A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.

[136]  Brian Seed,et al.  Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule , 2000, Nature Immunology.

[137]  G. Andrei,et al.  Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors. , 2000, The Journal of investigative dermatology.

[138]  A. Sesink,et al.  Red meat and colon cancer: dietary haem, but not fat, has cytotoxic and hyperproliferative effects on rat colonic epithelium. , 2000, Carcinogenesis.

[139]  R J Simpson,et al.  A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. , 2000, Molecular cell.

[140]  A. Sesink,et al.  Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. , 1999, Cancer research.

[141]  J. Groopman,et al.  Chemotherapy-induced anemia in adults: incidence and treatment. , 1999, Journal of the National Cancer Institute.

[142]  Z. Kırkalı,et al.  Serum Ferritin as a Clinical Markerfor Renal Cell Carcinoma: Influenc e of Tumor Size and Volume , 1999, Urologia Internationalis.

[143]  Kou-Juey Wu,et al.  Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. , 1999, Science.

[144]  R. Sinha,et al.  Heterocyclic amine content of pork products cooked by different methods and to varying degrees of doneness. , 1998, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[145]  M. Tso,et al.  Iron-induced apoptosis in the photoreceptor cells of rats. , 1998, Investigative ophthalmology & visual science.

[146]  V. Gordeuk,et al.  Hepatocellular carcinoma and African iron overload. , 1995, Gut.

[147]  J. Blatt Deferoxamine in children with recurrent neuroblastoma. , 1994, Anticancer research.

[148]  S. Toyokuni,et al.  DNA base modifications in renal chromatin of wistar rats treated with a renal carcinogen, ferric nitrilotriacetate , 1994, International journal of cancer.

[149]  B. Graubard,et al.  Moderate elevation of body iron level and increased risk of cancer occurrence and death , 1994, International journal of cancer.

[150]  T. Saika,et al.  Preferential repression of the H subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts. , 1993, The Journal of biological chemistry.

[151]  S. Elledge,et al.  Ribonucleotide reductase: regulation, regulation, regulation. , 1992, Trends in biochemical sciences.

[152]  M. Stahlhut,et al.  Iron enhances tumor growth. Observation on spontaneous mammary tumors in mice , 1991, Cancer.

[153]  S. White,et al.  Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. , 1990, Cancer research.

[154]  M. Björkholm,et al.  The incidence of cancer among blood donors. , 1990, International journal of epidemiology.

[155]  A. Donfrancesco,et al.  Effects of a single course of deferoxamine in neuroblastoma patients. , 1990, Cancer research.

[156]  K. McGlynn,et al.  Prognostic importance of serum transferrin and ferritin in childhood Hodgkin's disease , 1990, Cancer.

[157]  M. Stahlhut,et al.  Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. , 1988, Cancer research.

[158]  J. Eaton,et al.  Dietary suppression of colonic cancer fiber or phytate? , 1985, Cancer.

[159]  H. Sather,et al.  Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience. , 1985, Cancer research.

[160]  F. Lopez,et al.  Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[161]  A. Kubo,et al.  Serum Ferritin Levels in Patients with Cervical Cancer , 1980, Obstetrics and gynecology.

[162]  L. Pauling,et al.  Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[163]  N. Zinberg,et al.  Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer. , 1975, Journal of the National Cancer Institute.

[164]  D. Katz,et al.  Ferritin, a Hodgkin's disease associated antigen. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[165]  N. Zinberg,et al.  Isolation of ferritin from human mammary and pancreatic carcinomas by means of antibody immunoadsorbents. , 1974, Archives of biochemistry and biophysics.

[166]  H. Richmond Induction of Sarcoma in the Rat by Iron—Dextran Complex , 1959, British medical journal.

[167]  G. Ball,et al.  Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen , 2009, Breast Cancer Research and Treatment.

[168]  J. J. Caro,et al.  Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. , 2001, Cancer.

[169]  D. Ferrigno,et al.  Serum ferritin levels in lung cancer patients. , 1992, European journal of cancer.

[170]  R. Stjernholm,et al.  Preliminary evaluation of platinum transferrin (MPTC-63) as a potential nontoxic treatment for breast cancer. , 1988, Cancer detection and prevention.

[171]  E. Weinberg Iron, infection, and neoplasia. , 1986, Clinical physiology and biochemistry.

[172]  G. Ozolins,et al.  WHO guidelines for drinking-water quality. , 1984, WHO chronicle.